Lisa M Ebert
Dr Lisa Ebert has spent over 20 years researching the immune system, cancer, and interactions between the two. She completed her PhD in 2002 at the University of Adelaide, and then undertook postdoctoral research positions at the University of Bern in Switzerland (2002 – 2005) and at the Ludwig Institute for Cancer Research in Melbourne (2005 – 2010). During this time, she developed a focus on understanding how the immune system interacts with cancer, and using this knowledge to develop and improve cancer immunotherapies. In 2011, she returned to Adelaide as Senior Research Fellow at the Centre for Cancer Biology – a unique alliance between the South Australian public health system and the University of South Australia. Her current research is focussed on developing CAR-T cell therapies for brain cancer, and identifying key factors which determine the success of checkpoint blockade immunotherapies in melanoma patients. These studies are conducted at the interface between laboratory and clinic, with close ties to the Royal Adelaide Hospital Cancer Clinical Trials Unit.
Abstracts this author is presenting: